High levels of cerebrospinal fluid glutamate in Rett syndrome

Pediatric Neurology

Volumn 15, Issue 3, 1996, Pages 213-216

  Lappalainen, Raija ^a   Riikonen, Raili S ^b  

^a UNIVERSITY OF HELSINKI AND HELSINKI UNIVERSITY HOSPITAL   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTIC ACID; EXCITATORY AMINO ACID; GLUTAMATE RECEPTOR; GLUTAMIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NERVE GROWTH FACTOR;

ADOLESCENT; ARTICLE; BREATHING DISORDER; CHILD; CLINICAL ARTICLE; DRUG CEREBROSPINAL FLUID LEVEL; EPILEPSY; HUMAN; INFANT; NERVE CELL DIFFERENTIATION; NERVE INJURY; PRIORITY JOURNAL; RETT SYNDROME;

ADOLESCENT; AMINO ACIDS; ASPARTIC ACID; CHILD; CHILD, PRESCHOOL; FEMALE; GLUTAMIC ACID; HUMANS; INFANT; RETT SYNDROME;

EID: 0030273345     PISSN: 08878994     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0887-8994(96)00218-4     Document Type: Article

References (22)

1. [1] Rett A, Uber ein cerebral-atrophisches Syndrom bei Hyperammonämie. Wein: Brüder Hollinek, 1966:1-68.
2. [2] Diagnostic Criteria Work Group. Diagnostic criteria for Rett syndrome. Ann Neurol 1988;23:425-8.
3. [3] Beal MF. Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses? Ann Neurol 1992;31:119-30.
4. [4] Baker AJ, Moulton RJ, MacMillan VH, Shedden PM. Excitatory amino acids in cerebrospinal fluid following traumatic brain injury in humans. J Neurosurg 1993;79:369-72.
5. [5] Lipton SA, Rosenberg PA. Excitatory amino acids as a final common pathway for neurologic disorders. N Engl J Med 1994;330:613-21.
6. [6] Valtonen P, Haapalinna A, Riekkinen P, Halonen T. Effect of alfa-2-adrenergic drugs dexmedetomidine and atipamezole on extracellular amino acid levels in vivo. Eur J Pharmacol 1995;285:239-46.
7. [7] Hamberger A, Gillberg C, Palm A, Hagberg B. Elevated CSF glutamate in Rett syndrome. Neuropediatrics 1992;23:212-3.
8. [8] Hattori H, Wasterlain G. Excitatory amino acids in the developing brain: Ontogeny, plasticity, and excitotoxicity. Pediatr Neurol 1990;6:219-28.
9. [9] McDonald JW, Johnston MV. Physiological and pathophysiological roles of excitatory amino acids during central nervous system development. Brain Res Rev 1990;15:41-70.
10. [10] Araki K, Harada M, Ueda Y, Takino T, Kuriyama K. Alteration of amino acid content of cerebrospinal fluid from patients with epilepsy. Acta Neurol Scand 1988;78:473-9.
11. [11] Wenk GL, O'Leary M, Nemeroff CB, Bissette G, Moser H, Naidu S. Neurochemical alterations in Rett syndrome. Dev Brain Res 1993;74:67-72.
12. [12] Gluckman PD, Williams CE. When and why do brain cells die? Dev Med Child Neurol 1992;34:1010-4.
13. [13] Meldrum BS. Excitatory amino acids in epilepsy and potential novel therapies. Epilepsy Res 1992;12:189-96.
14. [14] Kälviäinen R, Halonen T, Pitkänen A, Riekkinen PJ. Amino acid levels in the cerebrospinal fluid of newly diagnosed epileptic patients: Effect of vigabatrin and carbamazepine monotherapies. J Neurochem 1993;60:1244-50.
15. [15] Devinsky O, Emoto S. Nadi NS, Theodore WH. Cerebrospinal fluid levels of neuropeptides, cortisol, and amino acids in patients with epilepsy. Epilepsia 1993;34:255-61.
16. [16] Zafra F, Castrén E, Thoenen H, Lindholm D. Interplay between glutamate and gamma-aminobuturic acid transmitter systems in the physiological regulation of brain-derived neurotrophic factor and nerve growth factor synthesis in hippocampal neurons. Proc Natl Acad Sci USA 1991;88:10037-41.
17. [17] Lindholm D, Dechant G, Heisenberg C-P, Thoenen H. Brain-derived neurotrophic factor is a survival factor for cultured rat cerebellar granule neurons and protects them against glutamate-induced neurotoxicity. Eur J Neurosci 1993;5:1455-64.
18. [18] Frim DM, Short MP, Rosenberg WS, Simpson J, Breakefield XO, Isacson O. Local protective effects of nerve growth factor-secreting fibroblasts against excitotoxic lesions in the rat striatum. J Neurosurg 1993;78:267-73.
19. [19] Cohen-Cory S, Dreyfus CF, Black IB. NGF and excitatory neurotransmitters regulate survival and morphogenesis of cultured cerebellar Purkinje cells. J Neurosci 1991;11:462-71.
20. [20] Hanefeld F, Hagberg B, Percy A. Molecular and neurobiology aspects of Rett syndrome. Neuropediatrics 1995;26:60-1.
21. [21] Armstrong D. The neuropathology of Rett syndrome - Overview 1994. Neuropediatrics 1995;26:100-4.
22. [22] Lappalainen R, Lindholm D, Riikonen R. Low levels of nerve growth factor (NGF) in CSF of children with Rett syndrome. J Child Neurol 1996;11:296-300.